• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Paysign Inc.

    8/8/24 4:46:17 PM ET
    $PAYS
    EDP Services
    Technology
    Get the next $PAYS alert in real time by email
    S-8 POS 1 paysign_s8pos.htm AMENDMENT NO. 1

    As filed with the Securities and Exchange Commission on August 8, 2024

    Registration No. 333-281353

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT NO. 1

    TO

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    PAYSIGN, INC.
    (Exact name of registrant as specified in its charter)

     

    Nevada

     

    95-4550154

    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    2615 St. Rose Parkway
    Henderson, Nevada 89052

    (Address of Principal Executive Offices) (Zip Code)

     

     

    PAYSIGN, INC.

    2023 EQUITY INCENTIVE PLAN

    (Full Title of the Plan)

     

    Mark R. Newcomer

    Chief Executive Officer

    Paysign, Inc.

    2615 St. Rose Parkway
    Henderson, Nevada 89052
    (Name and Address of Agent for Service)

     

    (702) 453-2221

    (Telephone Number, Including Area Code, of Agent for Service)

     

     

    Copy to:

    Brian H. Blaney, Esq.

    Greenberg Traurig, LLP
    2375 E. Camelback Road, Suite 800

    Phoenix, Arizona 85016

    (602) 445-8000

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐   Non-accelerated filer ☒   Smaller reporting company ☒
    Accelerated filer ☐       Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

       

     

     

    Explanatory Note

     

    This Post-Effective Amendment No. 1 to Registration Statement on Form S-8 (this “Amendment No. 1”) is being filed solely to correct a clerical error that resulted in a missing signature on Exhibit 23.1, consent of Moss Adams LLP, independent registered public accounting firm, included as an exhibit to the Registration Statement on Form S-8 (File No. 333-281353) filed with the Securities and Exchange Commission on August 7, 2024 (the “Original Filing”). This Amendment No. 1 (i) includes an updated Exhibit 23.1 with the missing signature and (ii) updates Part II – Information Required in the Registration Statement—Item 8, Exhibits.

     

    Except as described above, this Amendment No. 1 does not update, amend or modify any other information, statement or disclosure contained in the Original Filing.

     

     

     

     

     

     

     

     

     

     

     2 

     

     

    PART II
    INFORMATION REQUIRED IN THE
    REGISTRATION STATEMENT

     

    Item 8. Exhibits.

     

    Exhibit Number

     

    Description

         
    5.1+   Opinion of Greenberg Traurig, LLP
         
    10.1   Paysign, Inc. 2023 Equity Incentive Plan (1)
         
    23.1*   Consent of Moss Adams LLP, independent registered public accounting firm
         
    23.2+   Consent of Greenberg Traurig, LLP (included in opinion filed as Exhibit 5.1)
         
    24.1+   Power of Attorney (included on signature page hereof)
         
    107+   Filing Fee Table

     

    +

    *

    Previously filed.

    Filed herewith.

    (1) Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on May 9, 2023 (File Number 001-38623).

     

     

     

     3 

     

      

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Henderson, State of Nevada, on


    August 8, 2024.

     

      PAYSIGN, INC.
         
      By: /s/ Mark R. Newcomer
        Mark R. Newcomer
        Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature

    Title

    Date

         

    /s/ Mark R. Newcomer

    Chief Executive Officer, President, Director and Chairman
    (Principal Executive Officer)
    August 8, 2024
    Mark R. Newcomer
         

    *

    Chief Financial Officer and Treasurer
    (Principal Financial Officer and Principal Accounting Officer)
    August 8, 2024
    Jeff Baker
         

    *

    Chief Payments Officer and Director August 8, 2024
    Matthew Lanford
         

    *

    Executive Vice President and Director August 8, 2024
    Joan M. Herman
         

    *

    Director August 8, 2024
    Dan R. Henry
         

    *

    Director August 8, 2024
    Bruce Mina
         

    *

    Director August 8, 2024
    Jeffrey B. Newman
         

    *

    Director August 8, 2024
    Dennis Triplett

     

     

    * By: /s/ Mark R. Newcomer
      Name: Mark R. Newcomer
      Title: Attorney-in-fact

     

     

     

     4 

    Get the next $PAYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Strobo Robert sold $109,400 worth of shares (20,000 units at $5.47), decreasing direct ownership by 6% to 327,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    12/12/25 6:08:20 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Legal Officer Strobo Robert was granted 100,000 shares, increasing direct ownership by 40% to 347,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:46 PM ET
    $PAYS
    EDP Services
    Technology

    CEO Newcomer Mark was granted 200,000 shares, increasing direct ownership by 2% to 8,950,728 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:31 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    EDP Services
    Technology

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    EDP Services
    Technology

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format. The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign's Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3. Investors interested in registering may contact their Oppe

    1/21/26 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

    Dynamic Business Rules Demonstrates the Company's Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries, today announced its annual performance analysis of pharmaceutical copay programs. The company added 55 programs during 2025, exiting the year with 131 programs – many incorporating Paysign's Dynamic Business Rules feature, which saved pharmaceutical clients more than $325 million by mitigating the harmful financial impact of copay maximizers on patients and program sponso

    1/7/26 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas. The conference is an annual invitation-only event, featuring quality public companies to interact with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats. Paysign's Chief Financial Officer, Jeff Baker,

    11/13/25 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    SEC Filings

    View All

    SEC Form 10-Q filed by Paysign Inc.

    10-Q - Paysign, Inc. (0001496443) (Filer)

    11/13/25 7:17:54 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    11/12/25 5:09:55 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    9/15/25 9:01:05 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    EDP Services
    Technology

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    EDP Services
    Technology

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Third Quarter 2025 Financial Results

    Delivered strong performance with record revenue and improved profitability Third quarter 2025 total revenues of $21.60 million, up 41.6% from third quarter 2024 Third quarter 2025 net income of $2.22 million, up 54.2% from $1.44 million a year ago, while diluted earnings per share was $0.04 versus $0.03 for third quarter 2024 Third quarter 2025 Adjusted EBITDA of $5.04 million (23.3% of revenues), up 78.1% from $2.83 million (18.5% of revenues) a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.05 for third quarter 20241 Year-over-year plasma revenue increased 12.4% to $12.86 million; exited the quarter with 595 plasma centers, an increase of 117 plasma ce

    11/12/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports First Quarter 2025 Financial Results

    First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

    5/8/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology